Inherited Dysfunction of Sarcoplasmic Reticulum Ca2+ Handling and Arrhythmogenesis

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2011 Apr 2

PMID 21454795

Citations 211

Authors

Silvia G Priori

S R Wayne Chen

Affiliations

Soon will be listed here.

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disease occurring in patients with a structurally normal heart: the disease is characterized by life-threatening arrhythmias elicited by stress and emotion. In 2001, the ryanodine receptor was identified as the gene that is linked to CPVT; shortly thereafter, cardiac calsequestrin was implicated in the recessive form of the same disease. It became clear that abnormalities in intracellular Ca(2+) regulation could profoundly disrupt the electrophysiological properties of the heart. In this article, we discuss the molecular basis of the disease and the pathophysiological mechanisms that are impacting clinical diagnosis and management of affected individuals. As of today, the interaction between basic scientists and clinicians to understand CPVT and identify new therapeutic strategies is one of the most compelling examples of the importance of translational research in cardiology.

Citing Articles

Flecainide Specifically Targets the Monovalent Countercurrent Through the Cardiac Ryanodine Receptor, While a Dominant Opposing Ca/Ba Current Is Present.

Gaburjakova J, Domsicova M, Poturnayova A, Gaburjakova M Int J Mol Sci. 2025; 26(1.

PMID: 39796059 PMC: 11719481. DOI: 10.3390/ijms26010203.

Dual calcium-voltage optical mapping of regional voltage and calcium signals in intact murine -R2474S hearts.

Li Y, Liu Z, OShea C, Li J, Luo X, Chen T J Mol Cell Cardiol Plus. 2024; 10:100121.

PMID: 39697246 PMC: 11649530. DOI: 10.1016/j.jmccpl.2024.100121.

Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart.

Paudel R, Jafri M, Ullah A Curr Issues Mol Biol. 2024; 46(11):12886-12910.

PMID: 39590361 PMC: 11592891. DOI: 10.3390/cimb46110767.

Identifying the Pathogenic Variants in Heart Genes in Vietnamese Sudden Unexplained Death Victims by Next-Generation Sequencing.

Nguyen Tat T, Lien N, Luu Sy H, Ta Van T, Dang Viet D, Nguyen Thi H Diagnostics (Basel). 2024; 14(17).

PMID: 39272661 PMC: 11394071. DOI: 10.3390/diagnostics14171876.

p38γ/δ activation alters cardiac electrical activity and predisposes to ventricular arrhythmia.

Romero-Becerra R, Cruz F, Mora A, Lopez J, Ponce-Balbuena D, Allan A Nat Cardiovasc Res. 2024; 2(12):1204-1220.

PMID: 39196141 DOI: 10.1038/s44161-023-00368-x.

References

Amador F, Liu S, Ishiyama N, Plevin M, Wilson A, MacLennan D . Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop. Proc Natl Acad Sci U S A. 2009; 106(27):11040-4. PMC: 2708722. DOI: 10.1073/pnas.0905186106. View

Kubalova Z, Gyorke I, Terentyeva R, Viatchenko-Karpinski S, Terentyev D, Williams S . Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes. J Physiol. 2004; 561(Pt 2):515-24. PMC: 1665374. DOI: 10.1113/jphysiol.2004.073940. View

Mohamed U, Napolitano C, Priori S . Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007; 18(7):791-7. DOI: 10.1111/j.1540-8167.2007.00766.x. View

Kim E, Youn B, Kemper L, Campbell C, Milting H, Varsanyi M . Characterization of human cardiac calsequestrin and its deleterious mutants. J Mol Biol. 2007; 373(4):1047-57. DOI: 10.1016/j.jmb.2007.08.055. View

Liu N, Ruan Y, Denegri M, Bachetti T, Li Y, Colombi B . Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. J Mol Cell Cardiol. 2010; 50(1):214-22. DOI: 10.1016/j.yjmcc.2010.10.001. View

Yamamoto T, Yano M, Xu X, Uchinoumi H, Tateishi H, Mochizuki M . Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation. 2008; 117(6):762-72. DOI: 10.1161/CIRCULATIONAHA.107.718957. View

Knollmann B . New roles of calsequestrin and triadin in cardiac muscle. J Physiol. 2009; 587(Pt 13):3081-7. PMC: 2727016. DOI: 10.1113/jphysiol.2009.172098. View

Lakatta E, Guarnieri T . Spontaneous myocardial calcium oscillations: are they linked to ventricular fibrillation?. J Cardiovasc Electrophysiol. 1993; 4(4):473-89. DOI: 10.1111/j.1540-8167.1993.tb01285.x. View

dAmati G, Bagattin A, Bauce B, Rampazzo A, Autore C, Basso C . Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates. Hum Pathol. 2005; 36(7):761-7. DOI: 10.1016/j.humpath.2005.04.019. View

10.

MacLennan D, Zvaritch E . Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta. 2010; 1813(5):948-64. DOI: 10.1016/j.bbamcr.2010.11.009. View

11.

Shannon T, Ginsburg K, Bers D . Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J. 2000; 78(1):334-43. PMC: 1300641. DOI: 10.1016/S0006-3495(00)76596-9. View

12.

Lakatta E . Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc Res. 1992; 26(3):193-214. DOI: 10.1093/cvr/26.3.193. View

13.

Fernandez-Velasco M, Rueda A, Rizzi N, Benitah J, Colombi B, Napolitano C . Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2008; 104(2):201-9, 12p following 209. PMC: 2796688. DOI: 10.1161/CIRCRESAHA.108.177493. View

14.

Tiso N, Stephan D, Nava A, Bagattin A, Devaney J, Stanchi F . Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001; 10(3):189-94. DOI: 10.1093/hmg/10.3.189. View

15.

Laver D . Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites. Biophys J. 2007; 92(10):3541-55. PMC: 1853142. DOI: 10.1529/biophysj.106.099028. View

16.

Jiang D, Wang R, Xiao B, Kong H, Hunt D, Choi P . Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res. 2005; 97(11):1173-81. DOI: 10.1161/01.RES.0000192146.85173.4b. View

17.

Knollmann B, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K . Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006; 116(9):2510-20. PMC: 1551934. DOI: 10.1172/JCI29128. View

18.

Tiso N, Salamon M, Bagattin A, Danieli G, Argenton F, Bortolussi M . The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations. Biochem Biophys Res Commun. 2002; 299(4):594-8. DOI: 10.1016/s0006-291x(02)02689-x. View

19.

Gyorke I, Hester N, Jones L, Gyorke S . The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J. 2004; 86(4):2121-8. PMC: 1304063. DOI: 10.1016/S0006-3495(04)74271-X. View

20.

Fabiato A . Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983; 245(1):C1-14. DOI: 10.1152/ajpcell.1983.245.1.C1. View